---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-032123"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:20:23.947784+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioLife Solutions Q1 revenue up 25% YoY to $27.5M; net income $1.2M

## Summary
- Total revenue $27.5M, +25% YoY from $22.1M; GAAP net income $1.2M vs $0.3M in Q1 2025.
- Non-GAAP adjusted EBITDA $6.2M (22% of revenue) vs $5.4M (24% of revenue) in Q1 2025.
- GAAP EPS $0.02; GAAP gross margin 64% (down from 67% YoY); adjusted gross margin 64% (down from 68%).
- Reiterated FY 2026 guidance: revenue $112.5-115.0M, mid-60% gross margin, full-year net income.
- Biopreservation media embedded in 17 commercial CGTs and ~250 ongoing U.S. clinical trials (70% share).

## SEC filing metadata
- accession: 0001628280-26-032123
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828026032123/0001628280-26-032123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828026032123/blfs-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-032123
- JSON: https://secwatch.observer/filing/0001628280-26-032123.json
- Plain text: https://secwatch.observer/filing/0001628280-26-032123.txt

## Source-grounded claims
- claim_id: bbd28b6542b978043e847d630ccde9b6fa314e85
  claim: BIOLIFE SOLUTIONS INC reported the three months ended March 31, 2026 results: revenue $27.5 million, net income $1.2 million, EPS $0.02. Guidance reaffirmed.
  evidence_excerpt: BioLife Solutions Reports First Quarter 2026 Financial Results Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross margin of 64% GAAP net income of $1.2 million and non-GAAP adjusted EBITDA of $6.2 million or 22% of revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828026032123/0001628280-26-032123-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.